Niki BioSolutions, Inc. (NIKI) — Institutional Holders, Q2 2026
5 institutional investment managers reported a NIKI position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $74.2K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
NIKI in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- JANE STREET GROUPNew · +58,461 sh+$45.7K
- CITIGROUPNew · +6,398 sh+$5.0K
Biggest sellers
- CITADEL ADVISORSTrimmed · -67,928 sh-$53.1K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPSold out · -16,777 sh-$13.1K
- XTX Topco LtdSold out · -15,061 sh-$11.8K
- MORGAN STANLEYSold out · -13,262 sh-$10.4K
- RENAISSANCE TECHNOLOGIESSold out · -11,838 sh-$9.3K
NIKI 13F holders ranked 1–5 of 5
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | JANE STREET GROUP#1 · 58,461 sh | 58,461 | $45.7K | 0.00% | New |
| 2 | CITADEL ADVISORS#2 · 24,492 sh | 24,492 | $19.2K | 0.00% | -73.5% |
| 3 | CITIGROUP#3 · 6,398 sh | 6,398 | $5.0K | 0.00% | New |
| 4 | OSAIC#4 · 5,500 sh | 5,500 | $4.3K | 0.00% | 0.0% |
| 5 | SBI Securities , Ltd.#5 · 7 sh | 7 | $5.00 | — | 0.0% |
Funds that sold out of NIKI in Q2 2026 (5)
Held NIKI at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP16,777 sh | 16,777 | $13.4K |
| XTX Topco Ltd15,061 sh | 15,061 | $12.0K |
| MORGAN STANLEY13,262 sh | 13,262 | $10.6K |
| RENAISSANCE TECHNOLOGIES11,838 sh | 11,838 | $9.4K |
| UBS Group AG1,629 sh | 1,629 | $1.3K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.